ALS Ltd (ASX: ALQ) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

ALS Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $6.74 billion
P/E Ratio 25.96
Dividend Yield 2.80%
Shares Outstanding 484.17 million
Earnings per share 0.537
Dividend per share 0.39
Year To Date Return 8.40%
Earnings Yield 3.85%
Franking 20
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • ALS Ltd (ASX: ALQ)
    Latest News

    Share Gainers

    Why ALS, Clover, Computershare, & EML Payments shares are storming higher

    Clover Corporation Limited (ASX:CLV) and EML Payments Ltd (ASX:EML) shares are two of four storming notably higher today...

    Read more »

    Share Fallers

    Why ALS, CBA, Corporate Travel Management, & Mesoblast are dropping lower

    Commonwealth Bank of Australia (ASX:CBA) and Corporate Travel Management Ltd (ASX:CTD) shares are two of four dropping lower today...

    Read more »

    ⏸️ TMF AMP

    ASX 200 down 0.55%: Big four banks drag the market lower

    Commonwealth Bank of Australia (ASX:CBA) and Virgin Money UK PLC (ASX:VUK) shares are on the move on the ASX 200…

    Read more »

    a woman
    ⏸️ TMF AMP

    ASX 200 weekly wrap: bear market rollercoaster continues

    Here on our ASX 200 Foolish weekly wrap, we look at some of the things that moved the S&P/ASX 200…

    Read more »

    a woman
    Share Gainers

    Why this ASX 200 share smashed the market on Friday

    The ALS Ltd (ASX:ALQ) share price was one of the best performers on the ASX 200 on Friday. Here's why…

    Read more »

    a woman
    Share Market News

    ALL ORDINARIES finishes lower Wednesday: 8 ASX shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished lower on Wednesday, here are 8 ASX shares you missed.

    Read more »

    a woman
    Share Market News

    Top brokers name 3 ASX shares to sell today

    ALS Ltd (ASX:ALQ) shares are one of three that top brokers have named as sells this week. Here's why they…

    Read more »

    a woman
    Share Market News

    ASX 200 lunch update: Westpac & WiseTech lower, Lynas higher

    Lynas Corporation Ltd (ASX:LYC), Westpac Banking Corp (ASX:WBC), and WiseTech Global Ltd (ASX:WTC) shares are making waves on the ASX…

    Read more »

    a woman
    52-Week Highs

    Why ResMed and these ASX shares just stormed to 52-week highs

    The ResMed Inc (ASX:RMD) share price is one of three that hit a 52-week high or better during trade on Wednesday...

    Read more »

    a woman
    Share Market News

    ALL ORDINARIES finishes lower Wednesday: 8 ASX shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished lower on Wednesday, here are 8 ASX shares you missed.

    Read more »

    a woman
    Share Gainers

    Why ALS, Aristocrat Leisure, Technology One, & Webjet shares are surging higher

    The Aristocrat Leisure Limited (ASX:ALL) share price and the Technology One Limited (ASX:TNE) share price are two of four surging…

    Read more »

    a woman
    Share Market News

    ASX 200 lunch update: Aristocrat Leisure & Webjet higher, Westpac lower

    ALS Ltd (ASX:ALQ), Aristocrat Leisure Limited (ASX:ALL), and Webjet Limited (ASX:WEB) shares are making a splash on the ASX 200…

    Read more »

    Frequently Asked Questions

    Yes, ALS Ltd historically pays two partially or fully franked dividends a year.

    ALS Ltd generally pays its shareholder dividends in July and December

    ALS Ltd listed on the ASX on 18 July 1952.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    23 Nov 2023 $0.1960 20.00% Interim 14 Dec 2023
    09 Jun 2023 $0.1940 10.00% Final 06 Jul 2023
    24 Nov 2022 $0.2030 0.00% Interim 16 Dec 2022
    06 Jun 2022 $0.1700 30.00% Final 04 Jul 2022
    02 Dec 2021 $0.1580 30.00% Interim 17 Dec 2021
    07 Jun 2021 $0.1460 70.00% Final 05 Jul 2021
    26 Nov 2020 $0.0850 100.00% Interim 16 Dec 2020
    05 Jun 2020 $0.0610 70.00% Final 06 Jul 2020
    27 Nov 2019 $0.1150 30.00% Interim 16 Dec 2019
    03 Jun 2019 $0.1150 35.04% Final 01 Jul 2019
    29 Nov 2018 $0.1100 20.00% Interim 18 Dec 2018
    06 Jun 2018 $0.0900 40.00% Final 02 Jul 2018
    29 Nov 2017 $0.0800 40.00% Interim 18 Dec 2017
    07 Jun 2017 $0.0000 0.00% Final 03 Jul 2017
    05 Dec 2016 $0.0550 60.00% Interim 21 Dec 2016
    08 Jun 2016 $0.0600 40.00% Final 01 Jul 2016
    03 Dec 2015 $0.0750 25.07% Interim 18 Dec 2015
    11 Jun 2014 $0.2000 50.00% Final 02 Jul 2014
    07 Jun 2013 $0.2700 50.00% Final 02 Jul 2013
    05 Jun 2009 $0.4250 0.00% Final 01 Jul 2009
    01 Dec 2008 $0.4250 58.82% Interim 17 Dec 2008
    06 Jun 2008 $0.5100 58.82% Final 01 Jul 2008
    30 Nov 2007 $0.2975 58.82% Interim 17 Dec 2007
    06 Jun 2007 $0.3570 58.82% Final 02 Jul 2007
    29 Nov 2006 $0.2380 58.82% Interim 15 Dec 2006
    05 Jun 2006 $0.2900 100.00% Final 03 Jul 2006
    25 Nov 2005 $0.2100 100.00% Interim 20 Dec 2005
    04 Jun 2004 $0.1900 100.00% Final 01 Jul 2004
    28 Nov 2003 $0.1400 100.00% Interim 19 Dec 2003

    ALQ ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About ALS Ltd

    ALS Ltd (ASX: ALQ) is one of the world's largest laboratory testing, inspection, certification, and verification businesses. It operates from around 350 sites across 65 countries.

    Listed on the ASX in 1952, ALS operates three divisions: commodities, life sciences, and industrial. ALS's commodities segment traditionally generates the majority of the company's underlying earnings. It provides geochemistry, metallurgy, inspection, and mine site services for the mining industry globally.

    The company also provides environmental, pharmaceutical, and food and beverage testing and certification. ALS Ltd has a multi-billion dollar market capitalisation and is part of the ASX 100.

    ALQ Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    17 May 2024 $13.93 $0.08 0.58% 993,835 $13.73 $14.05 $13.69
    16 May 2024 $13.85 $0.40 2.97% 1,395,899 $13.64 $13.85 $13.55
    15 May 2024 $13.45 $-0.17 -1.25% 743,078 $13.78 $13.86 $13.45
    14 May 2024 $13.62 $0.32 2.41% 1,181,496 $13.50 $13.68 $13.41
    13 May 2024 $13.30 $0.04 0.30% 737,226 $13.31 $13.49 $13.25
    10 May 2024 $13.26 $0.16 1.22% 778,341 $13.17 $13.29 $13.06
    09 May 2024 $13.10 $-0.21 -1.58% 937,150 $13.34 $13.37 $13.01
    08 May 2024 $13.31 $0.17 1.29% 828,945 $13.17 $13.31 $13.15
    07 May 2024 $13.14 $0.07 0.54% 867,646 $13.09 $13.17 $13.03
    06 May 2024 $13.07 $-0.02 -0.15% 773,660 $13.13 $13.13 $12.87
    03 May 2024 $13.09 $0.08 0.61% 510,994 $13.08 $13.14 $12.88
    02 May 2024 $13.01 $0.06 0.46% 861,306 $12.99 $13.12 $12.93
    01 May 2024 $12.95 $-0.16 -1.22% 806,789 $13.00 $13.02 $12.86
    30 Apr 2024 $13.11 $-0.14 -1.06% 562,782 $13.33 $13.36 $13.07
    29 Apr 2024 $13.25 $0.18 1.38% 912,191 $13.19 $13.25 $12.94
    26 Apr 2024 $13.07 $-0.30 -2.24% 690,055 $13.20 $13.26 $12.95
    24 Apr 2024 $13.37 $0.10 0.75% 1,141,801 $13.28 $13.47 $13.23
    23 Apr 2024 $13.27 $-0.13 -0.97% 643,832 $13.36 $13.36 $13.21
    22 Apr 2024 $13.40 $0.36 2.76% 752,617 $13.14 $13.47 $13.12

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    19 Dec 2023 Nigel Garrard Buy 3,150 $40,477
    On-market trade.
    23 Nov 2023 Nigel Garrard Buy 3,250 $40,007
    On-market trade.
    26 Jul 2023 Malcom Deane Exercise 15,546 $175,669
    Conversion of securities. 40,514 Rights
    26 Jul 2023 Malcom Deane Buy 15,546 $175,669
    Conversion of securities.
    26 Jul 2023 Malcom Deane Issued 199,119 $2,250,044
    Issue of securities. 2,05,327 Rights, As per announcements on 04-08-2023
    06 Jun 2023 Bruce Phillips Buy 50,000 $58,401,243
    On-market trade.
    06 Jun 2023 Peter Possemiers Buy 1,740 $19,940
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Bruce John Phillips Non-Executive DirectorNon-Executive Chairman Aug 2015
    Bruce Phillips was appointed a Non Executive Director of the Company on 1 August 2015 and became Chairman on 26 July 2016 following the 2016 Annual General Meeting. Bruce
    is a qualified geophysicist with more than 40 years of technical, financial and managerial experience in the energy sector.
    Mr Nigel David Garrard Non-Executive Director Jun 2023
    Mr Garrard is a former CEO and executive at ASX Listed Group and Divisional levels across the fast-moving consumer goods and industrial/manufacturing sectors. He has 20 years experience as an ASX-listed CEO across three companies. In 2019, he retired as Managing Director and CEO of Orora Limited leading its demerger from Amcor, and the subsequent listing of Orora Limited on ASX in 2013. He was President of the Amcor Australasia and Packaging Distribution business group, Managing Director of Coca-Cola Amatils Food and Services Division, and Managing Director of SPC Ardmona. He is currently a non-executive director of Ansell Limited, a non-executive director of CSR Ltd, Chairman of Flinders Port Holdings Pty. Ltd and Chairman of the McMahon Services advisory board. He has international operations, manufacturing and supply chain management experience in North America, New Zealand and Asia across food services and processing, primary products and packaging as well as marketing. Nigel also has M&A experience in Australia and offshore including acquisitions, divestments, joint ventures, demergers and mergers.
    Dr John Francis Mulcahy Non-Executive Director Feb 2012
    John Mulcahy was appointed a Non Executive Director of the Company in 2012. He is Chairman of Orix Australia Corporation Limited, an unlisted public company (appointed March 2016),
    and Deputy Chairman of GWA Group Limited (appointed November 2010). He is also a current Non Executive Director of various Zurich Australia Insurance subsidiaries. John was previously a director and Chairman of both Mirvac Group Limited (November 2009 December 2022) and Coffey International
    Limited (September 2009 January 2016).
    Ms Tonianne Dwyer Non-Executive Director Jul 2016
    Tonianne Dwyer was appointed a Non-Executive Director of the Company on 1 July 2016. She has significant experience as a company director and executive working in finance, corporate strategy and mergers and acquisitions across a variety of sectors and international markets.
    Ms Leslie A Desjardins Non-Executive Director Nov 2019
    Leslie Desjardins was appointed a Non-Executive Director of the Company on 21 November 2019. She has a background as a CFO and senior financial and governance professional in a range of large multinational and global businesses.
    Dr Siddhartha Kadia Non-Executive Director Jan 2019
    Siddhartha Kadia was appointed a Non Executive Director of the Company in January 2019. Siddhartha was formerly President and CEO of EAG Laboratories, a global scientific testing company headquartered in San Diego. He has also
    been a Director of USA listed companies Newport Corporation (NSDQ: NEWP) and Volcano Corporation (NSDQ: VOLC). He is presently a Non-Executive Director of Nuvasive, Inc (appointed February 2022) and ATS (Applied Technical Services).
    Ms Erica Mann Non-Executive Director Mar 2024
    Ms Mann has 30-year career in DAX, NYSE, NSDAQ pharmaceutical, OTC and FMCG. Before retiring as an executive, Erica led Bayers Consumer Health Division,. Prior to joining Bayer, Ms Mann was President and General Manager of Pfizer Nutrition following its acquisition of Wyeth Inc where she served as Senior Vice President of Global Nutrition. This followed other senior executive roles of other 500 companies including Eli-Lily and Johnson & Johnson. She has held leadership positions in South Africa, Australia, New Zealand, Germany, Switzerland and the US. In addition to her executive experience in the nutrition and health industry, Ms Mann has experience with global and emerging markets across Africa, China, Russia and Brazil. Currently Ms Mann serves as an independent director of Perrigo, DSM-Firmenich and Kellogg (recently reincorporated as Kellanova) where she is a member of the Talent, Audit, and Social Responsibility & Public Policy Committees. Ms Mann previously chaired the Board of the World Self-Medication Industry Association and as an independent director with Blackmores Ltd and Solo- Flordis International.
    Mr Peter Possemiers Non-Executive Director Nov 2022
    Peter Possemiers was appointed a NonExecutive Director of the Company on 1 November 2022.He has a background as a TIC sector expert with almost 40 years experience working as a Senior Executive in leadership roles globally for SGS. He has lead teams both regionally and globally most notably SGSs global Environment Health and Safety business, a CHF 550million business with a global headcount which exceeded 6000. As Executive Vice President, he was a member of the SGS Operations Council with responsibility for the strategic growth and profitability of the business, leading 15 strategic acquisitions.
    Mr Malcom Deane Chief Strategy Officer General Manager Life Sciences - Food & Pharma Americas GeneralChief Executive OfficerManaging Director Mar 2023
    Mr Deane researched legal frameworks on specific issues including corporate, insurance, agricultural and antitrust issues. Cooperated in merger control cases. He monitored status of torts, civil and commercial lawsuits in different courts. Also, served as a member of different teams of lawyers advising international clients on cross-border transactions, capital markets matters, structuring of GDN and ADR programs and project finance. He counseled clients on a wide range of commercial issues including contractual law, corporate law, secured transactions, consumer credits and agribusiness matters. Advised clients on wealth and estate planning matters
    Mr Michael Paul Pearson Company Secretary Dec 2017
    -
    Michael Paul Pearson Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Paradice Investment Management Pty. Ltd. 17,551,248 3.60%
    The Vanguard Group, Inc. 16,378,763 3.40%
    Impax Asset Management Ltd 15,988,593 3.30%
    State Street Global Advisors Australia Ltd. 15,315,011 3.20%
    Capital Research Global Investors 15,303,262 3.20%
    Schroder Investment Management (Australia) Ltd. 13,603,883 2.80%
    Global Alpha Capital Management Ltd. 13,191,624 2.70%
    Dnr Capital Pty Ltd 10,957,501 2.30%
    First Sentier Investors (Growth) 10,774,500 2.20%
    Northcape Capital Pty. Ltd. 9,766,530 2.00%
    Macquarie Investment Management Global Ltd. 9,513,704 2.00%
    Australian Foundation Investment Company Limited 8,831,664 1.80%
    Baumber Gavin 8,538,373 1.80%
    Blackrock Institutional Trust Company, N.A. 8,488,776 1.60%
    Vanguard Investments Australia Ltd. 7,634,493 1.60%
    Credit Suisse Asset Management 7,147,120 1.50%
    Washington H. Soul Pattinson And Company Limited 7,079,431 1.50%
    Vinva Investment Management Limited 6,332,454 1.30%
    Greencape Capital Pty. Ltd. 6,306,181 1.30%
    Plato Investment Management Limited 5,971,208 1.20%

    Profile

    since

    Note